Murph
:)
- Messages
- 1,803
In this thread that people apparently still (!) aren't reading....
...I shared a study from some scientists from Monash University that is what made me think shark liver oil is a good idea.
(It's a byproduct of small dogfish sharks caught for meat so you don't have to feel bad about taking it.)
https://pubmed.ncbi.nlm.nih.gov/34146594/
J Lipid Res. 2021; 62: 100092.
Published online 2021 Jun 17. doi: 10.1016/j.jlr.2021.100092
PMCID: PMC8281607
PMID: 34146594
Here, we also observed a significant decrease in hsCRP after SLO supplementation. CRP is regarded as prothrombotic and proatherogenic in nature and is commonly used as a marker of systemic inflammation (46). Similar reductions in hsCRP levels in old-aged surgical patients with SLO supplementation have also been reported (28). Another study observed reduced serum complement (C3 and C4) and plasma vascular endothelial growth factor levels with SLO supplementation in obese individuals (45). Altogether, supplementation of SLO seems to have a role in modifying systemic inflammation in humans and could be effective in reducing the risk of progression of metabolic diseases to more advanced forms.
Bayesian Statistics Improves Biological Interpretability of Metabolomics Data from Human Cohorts (Brydges, Che, Lipkin, Fiehn 2023)
...I shared a study from some scientists from Monash University that is what made me think shark liver oil is a good idea.
(It's a byproduct of small dogfish sharks caught for meat so you don't have to feel bad about taking it.)
https://pubmed.ncbi.nlm.nih.gov/34146594/
J Lipid Res. 2021; 62: 100092.
Published online 2021 Jun 17. doi: 10.1016/j.jlr.2021.100092
PMCID: PMC8281607
PMID: 34146594
Shark liver oil supplementation enriches endogenous plasmalogens and reduces markers of dyslipidemia and inflammation
Sudip Paul,1,2 Adam Alexander T. Smith,1 Kevin Culham,1 Kevin A. Gunawan,1 Jacqueline M. Weir,1 Michelle A. Cinel,1 Kaushala S. Jayawardana,1 Natalie A. Mellett,1 Man K.S. Lee,3 Andrew J. Murphy,2,3 Graeme I. Lancaster,2,3 Paul J. Nestel,1 Bronwyn A. Kingwell,4 and Peter J. Meikle1,2,∗Here, we also observed a significant decrease in hsCRP after SLO supplementation. CRP is regarded as prothrombotic and proatherogenic in nature and is commonly used as a marker of systemic inflammation (46). Similar reductions in hsCRP levels in old-aged surgical patients with SLO supplementation have also been reported (28). Another study observed reduced serum complement (C3 and C4) and plasma vascular endothelial growth factor levels with SLO supplementation in obese individuals (45). Altogether, supplementation of SLO seems to have a role in modifying systemic inflammation in humans and could be effective in reducing the risk of progression of metabolic diseases to more advanced forms.